<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04632017</url>
  </required_header>
  <id_info>
    <org_study_id>8452</org_study_id>
    <nct_id>NCT04632017</nct_id>
  </id_info>
  <brief_title>Computerized Cardiotocography Monitoring of Fetuses With pPROM</brief_title>
  <acronym>COCA-PROM</acronym>
  <official_title>Computerized Cardiotocography Monitoring in Fetuses With Preterm Premature Rupture of Membranes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Campania &quot;Luigi Vanvitelli&quot;</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Campania &quot;Luigi Vanvitelli&quot;</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preterm premature rupture of membranes (PPROM) is associated with neonatal complications&#xD;
      leading to a high rate of cerebral palsy, sepsis, and death. Choosing the best time of&#xD;
      delivery is crucial to improve fetal outcome. The balance is between a premature delivery&#xD;
      exposing the infant to all the risk of prematurity, and keeping the baby in utero, prolonging&#xD;
      the exposure to an adverse intrauterine milieu. There are no objective and reproducible tools&#xD;
      to help in this decision-making process. Techniques most frequently used for fetal&#xD;
      surveillance are biased by high inter- and intra-observer variability. Computerized&#xD;
      cardiotocography (cCTG) identifies several objective parameters related to fetal heart rate&#xD;
      (FHR) to determine fetal well-being. cCTG has been successfully used in fetuses with&#xD;
      intrauterine growth restriction, but it has never been used in prospective studies to assess&#xD;
      its role in the management of fetuses with PPROM. The investigators designed a case control&#xD;
      study to highlight cCTG differences in PPROM pregnancies versus physiological pregnancies, to&#xD;
      establish the effectiveness in predicting adverse outcome, and to develop a score to predict&#xD;
      neonatal outcome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preterm premature rupture of membranes (PPROM) occurs in 2 to 3% of pregnancies and is&#xD;
      associated with higher maternal and neonatal morbidity and mortality. Neonatal complications&#xD;
      are primarily due to prematurity and to ascending infection of the amniotic cavity&#xD;
      (chorioamnionitis), leading to a high rate of cerebral palsy, intracranial hemorrhage,&#xD;
      sepsis, pneumonia, and death. Every physician is confronted with an extremely difficult and&#xD;
      at the same time of paramount importance decision, when it comes to establish the timing of&#xD;
      the delivery of a premature fetus with PPROM. The balance is between delivering a premature&#xD;
      infant exposed to all the risk of prematurity, and keeping the baby in utero, prolonging the&#xD;
      exposure to an adverse intrauterine milieu. At present, there are no objective and&#xD;
      reproducible tools to help in this decision-making process. The technique most frequently&#xD;
      used for fetal surveillance is cardiotocography (CTG). Assessment of the fetal heart rate is&#xD;
      classified subjectively as 'reassuring' or 'not reassuring'. Dawes and Redman have suggested&#xD;
      computerized CTG (cCTG), which eliminates inter- and intra-observer variability, identifying&#xD;
      several objective parameters to determine fetal well-being. After the multicentre&#xD;
      TRUFFLE-Study, cCTG became the best tool to manage fetuses with intrauterine growth&#xD;
      restriction (IUGR). However, the use of cCTG has never been investigated in prospective&#xD;
      studies to assess its role in the management of fetuses with PPROM. Of note, amniotic fluid&#xD;
      concentration of glucose, lactate, interleukin-6 (IL-6), and matrix metalloproteinase-8&#xD;
      (MMP-8) have been associated with neonatal septicemia, chorioamnionitis, preterm birth,&#xD;
      and/or fetal inflammatory response syndrome in women with pPROM.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Preterm birth rate</measure>
    <time_frame>Less than 37 weeks gestation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gestational age at delivery</measure>
    <time_frame>Time of delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preterm birth rates</measure>
    <time_frame>Less than 24, 28, 34 weeks gestation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Birth weight</measure>
    <time_frame>Time of delivery</time_frame>
    <description>Weight of the baby at the time of delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low birth weight rate</measure>
    <time_frame>Time of delivery</time_frame>
    <description>Birth weight &lt;2500g</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal death rate</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite adverse neonatal outcomes</measure>
    <time_frame>Between birth and 28 days of age</time_frame>
    <description>Number of neonates who will have at least one of the following:&#xD;
necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH) (grade 3 or higher), respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), retinopathy (ROP), blood-culture proven sepsis and neonatal death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal outcomes</measure>
    <time_frame>Between birth and 28 days after the birth</time_frame>
    <description>Number of mothers who will have at least one of the following:&#xD;
sepsis, histological chorioamnionitis, hysterectomy, intensive care unit admission.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dawes and Redman indices</measure>
    <time_frame>between 24 and 34 weeks of gestation</time_frame>
    <description>determined by computer analysis of the fetal heart tracing</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cardiotocography</condition>
  <condition>Premature Rupture of Membrane</condition>
  <condition>Rupture of Membranes; Premature</condition>
  <condition>Sepsis</condition>
  <condition>Premature Birth</condition>
  <arm_group>
    <arm_group_label>pPROM</arm_group_label>
    <description>Singleton pregnancies admitted for pPROM to the Obstetrics ward</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Healthy pregnant women matched for gestational age</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Computerized cardiotocography</intervention_name>
    <description>To compare Dawes and Redman indices as determined by computer analysis of the fetal heart tracing</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>pPROM</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Singleton pregnancies admitted for pPROM to the Obstetrics ward of this Hospital will be&#xD;
        recruited after informed consent.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  pPROM between 24 and 34 weeks (w)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  multiple pregnancy, structural fetal anomalies, preexisting or gestational diabetes&#xD;
             mellitus and\or hypertension, intrauterine growth restriction.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Antonio Schiattarella, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Campania &quot;Luigi Vanvitelli&quot;</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maddalena Morlando, MD</last_name>
    <phone>+39 333 426 3110</phone>
    <email>madmorlando@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fabiana Savoia, MD</last_name>
    <email>dott.fabianasavoia@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Campania &quot;Luigi Vanvitelli&quot;</name>
      <address>
        <city>Naples</city>
        <zip>80138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maddalena Morlando, MD</last_name>
      <phone>+39 333 426 3110</phone>
      <email>madmorlando@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Fabiana Savoia, MD</last_name>
      <email>dott.fabianasavoia@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Antonio Schiattarella, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Conte, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 10, 2020</study_first_submitted>
  <study_first_submitted_qc>November 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2020</study_first_posted>
  <last_update_submitted>November 16, 2020</last_update_submitted>
  <last_update_submitted_qc>November 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Campania &quot;Luigi Vanvitelli&quot;</investigator_affiliation>
    <investigator_full_name>Maddalena Morlando</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>cardiotocography</keyword>
  <keyword>Premature Rupture of Membrane</keyword>
  <keyword>computerized cardiotocography</keyword>
  <keyword>premature birth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Fetal Membranes, Premature Rupture</mesh_term>
    <mesh_term>Rupture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

